Literature DB >> 20686081

Incidence, risk factors, and outcomes of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus infections in Auckland, New Zealand.

S Muttaiyah1, G Coombs, S Pandey, P Reed, S Ritchie, D Lennon, S Roberts.   

Abstract

Panton-Valentine leukocidin (PVL) has been linked to invasive community-acquired methicillin-resistant Staphylococcus aureus infections. However, the association between disease and PVL-positive methicillin-susceptible Staphylococcus aureus (MSSA) has not been widely reported. We aimed to examine the epidemiology of PVL in clinical MSSA isolates from patients presenting to Auckland City Hospital. Four hundred eleven MSSA clinical isolates and 93 nasal carriage isolates were collected and tested for the presence of the lukSF-PV genes using PCR. The results were examined in light of host and disease factors. Multilocus sequence typing (MLST) was performed on a random subset of isolates to ensure that there was no single PVL-positive MSSA clone responsible for disease in Auckland. The prevalence of the lukSF-PV genes in MSSA isolates associated with disease (124/335; 37%) was not significantly different from the prevalence of the lukSF-PV genes in MSSA nasal carriage isolates (29/93; 31% [P = 0.33]). PVL-positive MSSA isolates in Auckland are genetically diverse and come from a number of different clonal complexes. PVL-positive infections peaked at between 10 and 20 years of age, with a subsequent decline. Pacific ethnicity, age, diagnosis of skin and soft tissue infection (SSTI), community-onset infection, and the need for surgical intervention were found by multivariate analysis to be independently associated with PVL-positive MSSA infection. More than one-third of MSSA infections in our patient population are caused by PVL-positive strains. Those patients with PVL-positive MSSA infection were more likely to be of Pacific ethnicity, be younger in age, have community-onset infection, have SSTI, and need surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686081      PMCID: PMC2953091          DOI: 10.1128/JCM.00911-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

2.  Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin.

Authors:  P D Ward; W H Turner
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

3.  Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality.

Authors:  P C Hill; M Birch; S Chambers; D Drinkovic; R B Ellis-Pegler; R Everts; D Murdoch; S Pottumarthy; S A Roberts; C Swager; S L Taylor; M G Thomas; C G Wong; A J Morris
Journal:  Intern Med J       Date:  2001-03       Impact factor: 2.048

4.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

5.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.

Authors:  D T Durack; A S Lukes; D K Bright
Journal:  Am J Med       Date:  1994-03       Impact factor: 4.965

6.  How clonal is Staphylococcus aureus?

Authors:  Edward J Feil; Jessica E Cooper; Hajo Grundmann; D Ashley Robinson; Mark C Enright; Tony Berendt; Sharon J Peacock; John Maynard Smith; Michael Murphy; Brian G Spratt; Catrin E Moore; Nicholas P J Day
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

7.  Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.

Authors:  Olivier Lesens; Cédric Methlin; Yves Hansmann; Véronique Remy; Martin Martinot; Colm Bergin; Pierre Meyer; Daniel Christmann
Journal:  Infect Control Hosp Epidemiol       Date:  2003-12       Impact factor: 3.254

8.  Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study.

Authors:  B Cribier; G Prévost; P Couppie; V Finck-Barbançon; E Grosshans; Y Piémont
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

9.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.

Authors:  M C Enright; N P Day; C E Davies; S J Peacock; B G Spratt
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

10.  Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils.

Authors:  Bettina Löffler; Muzaffar Hussain; Matthias Grundmeier; Michaela Brück; Dirk Holzinger; Georg Varga; Johannes Roth; Barbara C Kahl; Richard A Proctor; Georg Peters
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

View more
  17 in total

1.  Paediatric Osteomyelitis in Fiji.

Authors:  Basharat Munshi; Wiremu MacFater; Andrew G Hill; Eddie H McCaig
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

2.  Increases in Australian cutaneous abscess hospitalisations: 1999-2008.

Authors:  V L Vaska; G R Nimmo; M Jones; K Grimwood; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-08       Impact factor: 3.267

3.  Molecular characterization and panton-valentine leucocidin typing of community-acquired methicillin-sensitive Staphylococcus aureus clinical isolates.

Authors:  Kome Otokunefor; Tim Sloan; Angela M Kearns; Richard James
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

Review 4.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  The Dynamic of Staphylococcus aureus Nasal Carriage in Central Iran.

Authors:  Nasimeh Fard-Mousavi; Ghasem Mosayebi; Alireza Amouzandeh-Nobaveh; Alireza Japouni-Nejad; Ehsanollah Ghaznavi-Rad
Journal:  Jundishapur J Microbiol       Date:  2015-07-25       Impact factor: 0.747

6.  Engineering of the LukS-PV and LukF-PV subunits of Staphylococcus aureus Panton-Valentine leukocidin for diagnostic and therapeutic applications.

Authors:  Charles Emeka Okolie; Alan Cockayne; Christopher Penfold; Richard James
Journal:  BMC Biotechnol       Date:  2013-11-19       Impact factor: 2.563

7.  Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in New Zealand: rapid emergence of sequence type 5 (ST5)-SCCmec-IV as the dominant community-associated MRSA clone.

Authors:  Deborah A Williamson; Sally A Roberts; Stephen R Ritchie; Geoffrey W Coombs; John D Fraser; Helen Heffernan
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

Review 8.  The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis.

Authors:  Laura J Shallcross; Ellen Fragaszy; Anne M Johnson; Andrew C Hayward
Journal:  Lancet Infect Dis       Date:  2012-10-26       Impact factor: 25.071

9.  Community-onset Staphylococcus aureus infections presenting to general practices in South-eastern Australia.

Authors:  C M Bennett; G W Coombs; G M Wood; B P Howden; L E A Johnson; D White; P D R Johnson
Journal:  Epidemiol Infect       Date:  2013-07-18       Impact factor: 4.434

10.  Clinical and molecular epidemiology of community-onset invasive Staphylococcus aureus infection in New Zealand children.

Authors:  D A Williamson; S R Ritchie; S A Roberts; G W Coombs; M G Thomas; O Hannaford; M G Baker; D Lennon; J D Fraser
Journal:  Epidemiol Infect       Date:  2014-02-14       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.